SkinBiotherapeutics plc (SkinBio) is a UK-based life sciences company focused on the skin microbiome and dermatology. Originating from academic research, the company investigates beneficial skin bacteria and their derivatives to strengthen the skin barrier, help manage inflammation, and protect against pathogenic organisms.
SkinBio develops microbiome-derived actives and postbiotic ingredients for skincare, personal care, and consumer health applications. Its activities span discovery, fermentation and characterization of bioactives, formulation support, and clinical/consumer evaluation. The company commercializes its technology through partnerships, licensing agreements, and direct product initiatives, underpinned by an intellectual property portfolio covering microbiome-based approaches to skin health.